Epigenetic biomarkers in lung cancer

T Liloglou, NG Bediaga, BRB Brown, JK Field… - Cancer letters, 2014 - Elsevier
Lung cancer mortality is strongly associated with the predominant diagnosis of late stage
lesions that hampers effective therapy. Molecular biomarkers for early lung cancer detection …

Spatial intratumoral heterogeneity and temporal clonal evolution in esophageal squamous cell carcinoma

JJ Hao, DC Lin, HQ Dinh, A Mayakonda, YY Jiang… - Nature …, 2016 - nature.com
Esophageal squamous cell carcinoma (ESCC) is among the most common malignancies,
but little is known about its spatial intratumoral heterogeneity (ITH) and temporal clonal …

Targeting DNA methyltransferases in non-small-cell lung cancer

M Al-Yozbaki, I Jabre, NH Syed, CM Wilson - Seminars in cancer biology, 2022 - Elsevier
Despite the advances in treatment using chemotherapy or targeted therapies, due to static
survival rates, non-small cell lung cancer (NSCLC) is the major cause of cancer-related …

LncRNA-NEF suppressed oxaliplatin resistance and epithelial-mesenchymal transition in colorectal cancer through epigenetically inactivating MEK/ERK signaling

CJ Shi, ZH Xue, WQ Zeng, LQ Deng, FX Pang… - Cancer gene …, 2023 - nature.com
A major cause of oxaliplatin chemoresistance in colorectal cancer (CRC) is acquired
epithelial-mesenchymal transition (EMT) in cancer cells, making the cancer cells easy to …

The current understanding of asbestos-induced epigenetic changes associated with lung cancer

YY Cheng, EM Rath, A Linton, ML Yuen… - Lung Cancer: Targets …, 2020 - Taylor & Francis
Asbestos is a naturally occurring mineral consisting of extremely fine fibres that can become
trapped in the lungs after inhalation. Occupational and environmental exposures to asbestos …

Hypomethylation mediated by decreased DNMTs involves in the activation of proto-oncogene MPL in TK6 cells treated with hydroquinone

L Liu, X Ling, H Liang, Y Gao, H Yang, J Shao, H Tang - Toxicology letters, 2012 - Elsevier
Hydroquinone (HQ), one of the most important metabolites derived from benzene, is known
to be associated with acute myelogenous leukemia (AML) risk, however, its carcinogenic …

Somatic mutation distribution across tumour cohorts provides a signal for positive selection in cancer

M Boström, E Larsson - Nature communications, 2022 - nature.com
Cancer gene discovery is reliant on distinguishing driver mutations from a multitude of
passenger mutations in tumour genomes. While driver genes may be revealed based on …

Tumour biomarkers: homeostasis as a novel prognostic indicator

M Falco, G Palma, D Rea, D De Biase… - Open …, 2016 - royalsocietypublishing.org
The term 'personalized medicine'refers to a medical procedure that consists in the grouping
of patients based on their predicted individual response to therapy or risk of disease. In …

The role of DNA methylation as biomarkers in the clinical management of lung cancer

M Fleischhacker, D Dietrich, V Liebenberg… - Expert review of …, 2013 - Taylor & Francis
It is now widely accepted that cancer is caused by complex interactions between genetic
and epigenetic factors and the environment. Only in the last 20 years, DNA methylation has …

[HTML][HTML] DOK1 facilitates the advancement of ccRCC

W Xie, Y Zhang, B Shu, Z Zhang, R Zhang - Journal of Cancer, 2024 - pmc.ncbi.nlm.nih.gov
Background: Renal cell carcinoma (RCC) is one of the most common human cancers. Clear
cell renal cell carcinoma (ccRCC) is a major subtype of RCC. However, the molecular …